‘Spare’ Luteinizing Hormone Receptors: Facts and Fiction

Publication date: Available online 9 February 2018
Source:Trends in Endocrinology & Metabolism
Author(s): Livio Casarini, Daniele Santi, Manuela Simoni, Francesco Potì
It is common opinion that maximal activation of luteinizing hormone (LH)-dependent steroidogenic signal occurs at <1% of human LH/choriogonadotropin (hCG) receptor (LHCGR) occupancy. This effect would be a consequence of an excess of receptors expressed on the surface of theca cells, resulting in a pool of LHCGRs remaining unbound (spare). This concept was borrowed from historical pharmacological studies, when discrepancies between ligand–receptor binding and dose–response curves of cAMP were evaluated by treating mouse or rat Leydig cells with hCG in vitro. Recent findings demonstrated the specificity of LH- and hCG-dependent effects, receptor heterodimerization, and differing behaviors of rodent versus human gonadotropin-responsive cells, which may help to revise the 'spare' LHCGRs concept applied to human ovarian physiology and assisted reproduction.



http://ift.tt/2BiOR7E